New Delhi, 7 March 2025: AstraZeneca Pharma India Ltd on Thursday said it has received permission from India's drug regulator to import and sell sodium zirconium cyclosilicate powder for oral suspension used in treatment of hyperkalaemia -- higher than normal potassium level......
View Details

Related News

• Joint team of police, drugs department and anti-narcotics task force raided warehouse, recovered huge quantity of Tramadol Pills (22-03-2025)

---

• Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)

---

• One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)

---

• List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)

---

• DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)

---

• Skin specialists flag widespread quackery in Kerala (21-03-2025)

---

• SHRC orders criminal proceedings against fake doctor (21-03-2025)

---

• Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)

---

• CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)

---

• FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)

---